DSIP Peptide in Canada: Sequence, Literature and Lab Analysis

Delta sleep-inducing peptide, almost always shortened to DSIP, is a compact nine-residue sequence with a long and uneven research history. Labs ordering DSIP peptide in Canada tend to have two practical questions: what exactly is in the vial, and how much of the published literature can be relied on. This article answers both from a laboratory point of view. It covers the sequence and mass, where the literature is firm and where it is thin, how DSIP behaves on HPLC, which degradation products to watch for, and how to receive and log a multi-vial order so results stay traceable.

DSIP peptide in Canada: the nine-residue identity

DSIP is a linear peptide with free termini and no modifications. The key identity data are:

With three glycines and two alanines, most of the chain is small and flexible. The molecule is simple by peptide standards, which makes identity confirmation straightforward but leaves a few analytical details that are easy to overlook.

What the literature does and does not settle

DSIP was first isolated in the 1970s from the blood of rabbits by a Swiss research group, and its name comes from the slow-wave, or delta, EEG activity described in that early animal work. A great deal of the published research dates from the following two decades.

For anyone reviewing that body of work, a few points are worth keeping in mind:

• No confirmed receptor. Despite decades of study, a specific DSIP receptor has not been conclusively identified. Proposed mechanisms remain indirect.
• Uneven reproducibility. Reported findings vary between laboratories and models, and older studies often lack the analytical characterisation of the peptide that would be expected today.
• Search terms matter. Much of the early literature is indexed under the full name rather than the abbreviation. Searching both, along with “delta-sleep-inducing peptide” with its hyphen, gives a fuller picture.
• Stability in biological matrices. Short unmodified peptides are cleared quickly by peptidases in serum-containing systems, which complicates interpretation of older in-vitro and animal data.

The upshot for a research group is to treat DSIP as a compound with an interesting history and open questions, and to design experiments with thorough controls rather than relying on older conclusions.

Reading DSIP on a chromatogram

DSIP is polar and acidic. On a reversed-phase column it tends to elute early, so a method has to start at a low organic percentage and hold it long enough to separate the main peak from the solvent front and from closely eluting impurities. A gradient designed for larger or more hydrophobic peptides may push DSIP through too quickly to resolve anything useful.

Tryptophan at position 1 gives the molecule absorbance at 280 nm, so purity can be reported at either 280 or around 214 nm. The two figures will not match. The low-UV reading responds to peptide bonds in every species present, while the 280 nm reading only sees species that still contain an intact indole ring. An impurity that lost or modified the tryptophan, or a fragment lacking it, is under-counted at 280 nm. When two certificates for DSIP disagree, the detection wavelength is the first thing to compare.

How DSIP degrades

The sequence avoids some common weak points and carries one obvious one:

• Tryptophan oxidation. The indole ring is sensitive to light and oxygen. Oxidation products appear in the mass spectrum at +16 Da and +32 Da relative to the parent, and a kynurenine-type product can appear at +4 Da. Rising levels across a stored lot usually point to light or air exposure.
• No deamidation route. DSIP contains neither asparagine nor glutamine, so the familiar +1 Da deamidation products should not form.
• Modest aspartimide risk. Aspartate is followed by alanine rather than glycine or serine, the pairs most prone to aspartimide formation, so this route is less of a concern than in many sequences.
• Hydrolysis and moisture. As with any lyophilised peptide, absorbed water accelerates slow chemical change, so dry, cold storage matters.

Handling analytical stocks

Because DSIP carries a net negative charge at neutral pH, it generally dissolves readily in water or in a neutral to mildly basic buffer. Strongly acidic conditions bring it closer to its isoelectric point and can reduce solubility, which is worth remembering if a lab’s default is to use dilute acid for every peptide stock.

For in-vitro and analytical work, a few habits protect the material:

1. Let the sealed vial reach room temperature before opening, so condensation forms on the glass rather than on the powder.
2. Protect solutions from light, given the tryptophan.
3. Split stocks into single-use aliquots to avoid repeated freeze-thaw.
4. Record the solvent, concentration and preparation date on every aliquot label and in the inventory log.

Receiving a multi-vial DSIP order

When DSIP arrives in quantity, a quick, consistent check keeps the stock traceable across a long project:

• Confirm that the certificate’s calculated mass matches 848.8 g/mol for the free-acid sequence.
• Note the detection wavelength used for the purity figure, so later comparisons are like for like.
• Match each vial’s cap and crimp colour to the certificate on file and record the pairing.
• Log lot, vial count and the condition of each cake and the packaging on arrival.
• Move vials to cold, dark storage the same day, and aim to draw an entire study from one lot.

Mass and HPLC purity together confirm identity and uniformity, but they say nothing about endotoxin, sterility or residual solvents unless those tests are listed separately. Bulk Peptides products are third-party tested for purity by HPLC, and certificates are published for some products on the certificates of analysis page. The DSIP 5 mg vial ships from within Canada, and with mix-and-match volume pricing every vial in the cart counts toward the volume break.

DSIP is sold for in-vitro laboratory research only. It is not for human or veterinary use, and nothing in this article is guidance on preparation for, or use in, people or animals.